Logo image of SKGR

SK GROWTH OPPORTUNITIES CO-A (SKGR) Stock Fundamental Analysis

NASDAQ:SKGR - Nasdaq - KYG8192N1034 - Common Stock - Currency: USD

12.02  +0.58 (+5.07%)

After market: 11.75 -0.27 (-2.25%)

Fundamental Rating

1

Overall SKGR gets a fundamental rating of 1 out of 10. We evaluated SKGR against 0 industry peers in the Unkown industry. Both the profitability and financial health of SKGR have multiple concerns. SKGR has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year SKGR was profitable.
SKGR had a negative operating cash flow in the past year.
SKGR Yearly Net Income VS EBIT VS OCF VS FCFSKGR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 2M -2M 4M 6M 8M

1.2 Ratios

Industry RankSector Rank
ROA 3.74%
ROE 4.54%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SKGR Yearly ROA, ROE, ROICSKGR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 2 4 6 8

1.3 Margins

SKGR does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SKGR Yearly Profit, Operating, Gross MarginsSKGR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023

More info and screens

2

2. Health

2.1 Basic Checks

The number of shares outstanding for SKGR has been reduced compared to 1 year ago.
The debt/assets ratio for SKGR is higher compared to a year ago.
SKGR Yearly Shares OutstandingSKGR Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 5M 10M 15M 20M 25M
SKGR Yearly Total Debt VS Total AssetsSKGR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

SKGR has an Altman-Z score of 163.32. This indicates that SKGR is financially healthy and has little risk of bankruptcy at the moment.
A Debt/Equity ratio of 0.07 indicates that SKGR is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Altman-Z 163.32
ROIC/WACCN/A
WACCN/A
SKGR Yearly LT Debt VS Equity VS FCFSKGR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 50M 100M 150M 200M

2.3 Liquidity

SKGR has a Current Ratio of 0.08. This is a bad value and indicates that SKGR is not financially healthy enough and could expect problems in meeting its short term obligations.
SKGR has a Quick Ratio of 0.08. This is a bad value and indicates that SKGR is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.08
Quick Ratio 0.08
SKGR Yearly Current Assets VS Current LiabilitesSKGR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2M 4M 6M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for SKGR have decreased strongly by -36.01% in the last year.
EPS 1Y (TTM)-36.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%3.39%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

SKGR is valuated quite expensively with a Price/Earnings ratio of 54.64.
When comparing the Price/Earnings ratio of SKGR to the average of the S&P500 Index (26.86), we can say SKGR is valued expensively.
Industry RankSector Rank
PE 54.64
Fwd PE N/A
SKGR Price Earnings VS Forward Price EarningsSKGR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SKGR Per share dataSKGR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 0.1 0.15 0.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SKGR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SK GROWTH OPPORTUNITIES CO-A

NASDAQ:SKGR (4/10/2025, 8:00:02 PM)

After market: 11.75 -0.27 (-2.25%)

12.02

+0.58 (+5.07%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners104.21%
Inst Owner Change-52.96%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap5.55B
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 54.64
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 58.87
P/tB 58.87
EV/EBITDA N/A
EPS(TTM)0.22
EY1.83%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0
BVpS0.2
TBVpS0.2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.74%
ROE 4.54%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.08
Quick Ratio 0.08
Altman-Z 163.32
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-36.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%3.39%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-46.02%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y39.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y39.53%
OCF growth 3YN/A
OCF growth 5YN/A